• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用定性和定量成像特征评估肝内胆管细胞癌的预后。

Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features.

机构信息

Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1234, New York, NY, 10029-6574, USA.

BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

出版信息

Cancer Imaging. 2020 Jul 3;20(1):43. doi: 10.1186/s40644-020-00323-0.

DOI:10.1186/s40644-020-00323-0
PMID:32620153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7333305/
Abstract

BACKGROUND

To assess the performance of imaging features, including radiomics texture features, in predicting histopathologic tumor grade, AJCC stage, and outcomes [time to recurrence (TTR) and overall survival (OS)] in patients with intrahepatic cholangiocarcinoma (ICC).

METHODS

Seventy-three patients (26 M/47F, mean age 63y) with pre-operative imaging (CT, n = 37; MRI, n = 21; CT and MRI, n = 15] within 6 months of resection were included in this retrospective study. Qualitative imaging traits were assessed by 2 observers. A 3rd observer measured tumor apparent diffusion coefficient (ADC), enhancement ratios (ERs), and Haralick texture features. Blood biomarkers and imaging features were compared with histopathology (tumor grade and AJCC stage) and outcomes (TTR and OS) using log-rank, generalized Wilcoxon, Cox proportional hazards regression, and Fisher exact tests.

RESULTS

Median TTR and OS were 53.9 and 79.7 months. ICC recurred in 64.4% (47/73) of patients and 46.6% (34/73) of patients died. There was fair accuracy for some qualitative imaging features in the prediction of worse tumor grade (maximal AUC of 0.68 for biliary obstruction on MRI, p = 0.032, observer 1) and higher AJCC stage (maximal AUC of 0.73 for biliary obstruction on CT, p = 0.002, observer 2; and AUC of 0.73 for vascular involvement on MRI, p = 0.01, observer 2). Cox proportional hazards regression analysis showed that CA 19-9 [hazard ratio (HR) 2.44/95% confidence interval (CI) 1.31-4.57/p = 0.005)] and tumor size on imaging (HR 1.13/95% CI 1.04-1.22/p = 0.003) were significant predictors of TTR, while CA 19-9 (HR 4.08/95% CI 1.75-9.56, p = 0.001) and presence of metastatic lymph nodes at histopathology (HR 2.86/95% CI 1.35-6.07/p = 0.006) were significant predictors of OS. On multivariable analysis, satellite lesions on CT (HR 2.79/95%CI 1.01-7.15/p = 0.032, observer 2), vascular involvement on MRI (HR 0.10/95% CI 0.01-0.85/p = 0.032, observer 1), and texture feature MRI variance (HR 0.55/95% CI 0.31-0.97, p = 0.040) predicted TTR once adjusted for the independent predictors CA 19-9 and tumor size on imaging. Several qualitative and quantitative features demonstrated associations with TTR, OS, and AJCC stage at univariable analysis (range: HR 0.35-19; p < 0.001-0.045), however none were predictive of OS at multivariable analysis when adjusted for CA 19-9 and metastatic lymph nodes (p > 0.088).

CONCLUSIONS

There was reasonable accuracy in predicting tumor grade and higher AJCC stage in ICC utilizing certain qualitative and quantitative imaging traits. Serum CA 19-9, tumor size, presence of metastatic lymph nodes, and qualitative imaging traits of satellite lesions and vascular involvement are predictors of patient outcomes, along with a promising predictive ability of certain quantitative texture features.

摘要

背景

评估成像特征(包括放射组学纹理特征)在预测肝内胆管癌(ICC)患者的组织病理学肿瘤分级、AJCC 分期和结局(无复发生存时间 [TTR] 和总生存时间 [OS])方面的性能。

方法

本回顾性研究纳入了 73 例患者(26 例男性/47 例女性,平均年龄 63 岁),术前影像学检查(CT,n=37;MRI,n=21;CT 和 MRI,n=15)在切除术后 6 个月内进行。两位观察者评估了定性影像学特征。第三位观察者测量了肿瘤表观扩散系数(ADC)、增强比(ER)和 Haralick 纹理特征。使用对数秩检验、广义 Wilcoxon 检验、Cox 比例风险回归和 Fisher 精确检验比较血液生物标志物和影像学特征与组织病理学(肿瘤分级和 AJCC 分期)和结局(TTR 和 OS)。

结果

中位 TTR 和 OS 分别为 53.9 和 79.7 个月。73 例患者中有 64.4%(47/73)发生 ICC 复发,46.6%(34/73)的患者死亡。在预测更差的肿瘤分级方面,一些定性影像学特征具有中等准确性(MRI 上胆道梗阻的最大 AUC 为 0.68,p=0.032,观察者 1)和更高的 AJCC 分期(CT 上胆道梗阻的最大 AUC 为 0.73,p=0.002,观察者 2;MRI 上血管受累的 AUC 为 0.73,p=0.01,观察者 2)。Cox 比例风险回归分析显示,CA 19-9(风险比 [HR] 2.44/95%置信区间 [CI] 1.31-4.57/p=0.005)和影像学上的肿瘤大小(HR 1.13/95%CI 1.04-1.22/p=0.003)是 TTR 的显著预测因子,而 CA 19-9(HR 4.08/95%CI 1.75-9.56,p=0.001)和组织病理学上存在转移性淋巴结(HR 2.86/95%CI 1.35-6.07/p=0.006)是 OS 的显著预测因子。在多变量分析中,CT 上的卫星病变(HR 2.79/95%CI 1.01-7.15/p=0.032,观察者 2)、MRI 上的血管受累(HR 0.10/95%CI 0.01-0.85/p=0.032,观察者 1)和纹理特征 MRI 方差(HR 0.55/95%CI 0.31-0.97,p=0.040)在调整 CA 19-9 和影像学上的肿瘤大小这两个独立预测因子后,预测 TTR。在单变量分析中,一些定性和定量特征与 TTR、OS 和 AJCC 分期相关(范围:HR 0.35-19;p<0.001-0.045),但在调整 CA 19-9 和转移性淋巴结后,在多变量分析中均不能预测 OS(p>0.088)。

结论

利用某些定性和定量的成像特征,ICC 患者肿瘤分级和更高的 AJCC 分期的预测具有一定的准确性。血清 CA 19-9、肿瘤大小、转移性淋巴结的存在以及卫星病变和血管受累的定性影像学特征是患者预后的预测因子,而某些定量纹理特征具有良好的预测能力。

相似文献

1
Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features.使用定性和定量成像特征评估肝内胆管细胞癌的预后。
Cancer Imaging. 2020 Jul 3;20(1):43. doi: 10.1186/s40644-020-00323-0.
2
Prediction of the histopathologic findings of intrahepatic cholangiocarcinoma: qualitative and quantitative assessment of diffusion-weighted imaging.肝内胆管癌的组织病理学发现预测:扩散加权成像的定性和定量评估。
Eur Radiol. 2018 May;28(5):2047-2057. doi: 10.1007/s00330-017-5156-6. Epub 2017 Dec 12.
3
Intrahepatic cholangiocarcinoma: can imaging phenotypes predict survival and tumor genetics?肝内胆管癌:影像学表型能否预测生存和肿瘤遗传学?
Abdom Radiol (NY). 2018 Oct;43(10):2665-2672. doi: 10.1007/s00261-018-1505-4.
4
Diagnostic Performance and Prognostic Relevance of FDG Positron Emission Tomography/Computed Tomography for Patients with Extrahepatic Cholangiocarcinoma.FDG 正电子发射断层扫描/计算机断层扫描对肝外胆管癌患者的诊断性能和预后相关性。
Korean J Radiol. 2020 Dec;21(12):1355-1366. doi: 10.3348/kjr.2019.0891. Epub 2020 Aug 4.
5
Predictive value of the albumin-bilirubin grade on long-term outcomes of CT-guided percutaneous microwave ablation in intrahepatic cholangiocarcinoma.白蛋白-胆红素分级对 CT 引导下经皮微波消融治疗肝内胆管细胞癌长期疗效的预测价值。
Int J Hyperthermia. 2019;36(1):328-336. doi: 10.1080/02656736.2019.1567834. Epub 2019 Jan 28.
6
Intrahepatic cholangiocarcinoma: MRI texture signature as predictive biomarkers of immunophenotyping and survival.肝内胆管细胞癌:MRI 纹理特征作为免疫表型和生存的预测生物标志物。
Eur Radiol. 2021 Jun;31(6):3661-3672. doi: 10.1007/s00330-020-07524-y. Epub 2020 Nov 27.
7
Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.18-FDG PET/CT在可切除胆管癌管理中的诊断和预后作用
World J Surg. 2018 Mar;42(3):823-834. doi: 10.1007/s00268-017-4192-3.
8
MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma.MRI 特征可预测肝内胆管细胞癌中的微血管侵犯。
Cancer Imaging. 2020 Jun 23;20(1):40. doi: 10.1186/s40644-020-00318-x.
9
Prediction for early recurrence of intrahepatic mass-forming cholangiocarcinoma: quantitative magnetic resonance imaging combined with prognostic immunohistochemical markers.预测肝内肿块型胆管细胞癌的早期复发:定量磁共振成像结合预后免疫组织化学标志物。
Cancer Imaging. 2019 Jul 15;19(1):49. doi: 10.1186/s40644-019-0234-4.
10
Machine learning-based Radiomics analysis for differentiation degree and lymphatic node metastasis of extrahepatic cholangiocarcinoma.基于机器学习的影像组学分析在肝外胆管癌分化程度和淋巴结转移中的应用。
BMC Cancer. 2021 Nov 24;21(1):1268. doi: 10.1186/s12885-021-08947-6.

引用本文的文献

1
CT-Based Habitat Radiomics Combining Multi-Instance Learning for Early Prediction of Post-Neoadjuvant Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma.基于CT的影像组学联合多实例学习用于早期预测食管鳞状细胞癌新辅助治疗后淋巴结转移
Bioengineering (Basel). 2025 Jul 28;12(8):813. doi: 10.3390/bioengineering12080813.
2
To accurately predict lymph node metastasis in patients with mass-forming intrahepatic cholangiocarcinoma by using CT radiomics features of tumor habitat subregions.通过使用肿瘤栖息地亚区域的CT影像组学特征准确预测肿块型肝内胆管癌患者的淋巴结转移。
Cancer Imaging. 2025 Feb 26;25(1):19. doi: 10.1186/s40644-025-00842-8.
3

本文引用的文献

1
Intrahepatic Mass-forming Cholangiocarcinoma: Arterial Enhancement Patterns at MRI and Prognosis.肝内肿块型胆管细胞癌:MRI 动脉期增强模式与预后。
Radiology. 2019 Mar;290(3):691-699. doi: 10.1148/radiol.2018181485. Epub 2019 Jan 8.
2
Texture Analysis Based on Preoperative Magnetic Resonance Imaging (MRI) and Conventional MRI Features for Predicting the Early Recurrence of Single Hepatocellular Carcinoma after Hepatectomy.基于术前磁共振成像(MRI)和常规 MRI 特征的纹理分析预测肝细胞癌术后早期复发
Acad Radiol. 2019 Sep;26(9):1164-1173. doi: 10.1016/j.acra.2018.10.011. Epub 2018 Nov 10.
3
Intrahepatic cholangiocarcinoma: can imaging phenotypes predict survival and tumor genetics?
A preliminary study of developing an MRI-based model for postoperative recurrence prediction and treatment direction of intrahepatic cholangiocarcinoma.
基于磁共振成像(MRI)的肝内胆管癌术后复发预测及治疗方向模型开发的初步研究。
Radiol Med. 2024 Dec;129(12):1766-1777. doi: 10.1007/s11547-024-01910-y. Epub 2024 Nov 2.
4
Primary lung adenocarcinoma harboring upper mediastinal lymphatic skip metastasis of cervical squamous cell carcinoma: A case report and literature review.伴有宫颈鳞状细胞癌上纵隔淋巴跳跃转移的原发性肺腺癌:一例报告及文献复习
Oncol Lett. 2024 Aug 7;28(4):481. doi: 10.3892/ol.2024.14614. eCollection 2024 Oct.
5
Preoperative MRI features predicting very early recurrence of intrahepatic mass-forming cholangiocarcinoma after R0 resection: a comparison with the AJCC 8th edition staging system.预测肝内肿块型胆管癌R0切除术后极早期复发的术前MRI特征:与美国癌症联合委员会第8版分期系统的比较
Abdom Radiol (NY). 2024 Jan;49(1):21-33. doi: 10.1007/s00261-023-04038-1. Epub 2023 Oct 10.
6
Radiomics-based machine learning and deep learning to predict serosal involvement in gallbladder cancer.基于放射组学的机器学习和深度学习预测胆囊癌浆膜浸润。
Abdom Radiol (NY). 2024 Jan;49(1):3-10. doi: 10.1007/s00261-023-04029-2. Epub 2023 Oct 3.
7
Radiomic Analysis of Intrahepatic Cholangiocarcinoma: Non-Invasive Prediction of Pathology Data: A Multicenter Study to Develop a Clinical-Radiomic Model.肝内胆管癌的影像组学分析:病理数据的无创预测:一项开发临床影像组学模型的多中心研究
Cancers (Basel). 2023 Aug 22;15(17):4204. doi: 10.3390/cancers15174204.
8
Magnetic resonance imaging features of bile duct adenoma.胆管腺瘤的磁共振成像特征
Front Oncol. 2023 Aug 16;13:1180186. doi: 10.3389/fonc.2023.1180186. eCollection 2023.
9
Prediction of regional lymph node metastasis in intrahepatic cholangiocarcinoma: it's not all about size.预测肝内胆管细胞癌的区域淋巴结转移:大小并非唯一因素。
Abdom Radiol (NY). 2023 Oct;48(10):3063-3071. doi: 10.1007/s00261-023-03991-1. Epub 2023 Jun 24.
10
Immuno-genomic-radiomics to predict response of biliary tract cancer to camrelizumab plus GEMOX in a single-arm phase II trial.在一项单臂II期试验中,免疫基因组放射组学用于预测胆道癌对卡瑞利珠单抗联合GEMOX方案的反应。
JHEP Rep. 2023 Apr 22;5(7):100763. doi: 10.1016/j.jhepr.2023.100763. eCollection 2023 Jul.
肝内胆管癌:影像学表型能否预测生存和肿瘤遗传学?
Abdom Radiol (NY). 2018 Oct;43(10):2665-2672. doi: 10.1007/s00261-018-1505-4.
4
Prediction of the histopathologic findings of intrahepatic cholangiocarcinoma: qualitative and quantitative assessment of diffusion-weighted imaging.肝内胆管癌的组织病理学发现预测:扩散加权成像的定性和定量评估。
Eur Radiol. 2018 May;28(5):2047-2057. doi: 10.1007/s00330-017-5156-6. Epub 2017 Dec 12.
5
Impact of hepatocellular carcinoma heterogeneity on computed tomography as a prognostic indicator.肝细胞癌异质性对 CT 作为预后指标的影响。
Sci Rep. 2017 Oct 4;7(1):12689. doi: 10.1038/s41598-017-12688-7.
6
Modified staging classification for intrahepatic cholangiocarcinoma based on the sixth and seventh editions of the AJCC/UICC TNM staging systems.基于美国癌症联合委员会(AJCC)/国际抗癌联盟(UICC)TNM分期系统第六版和第七版的肝内胆管癌改良分期分类
Medicine (Baltimore). 2017 Aug;96(34):e7891. doi: 10.1097/MD.0000000000007891.
7
Cross-Sectional Imaging of Intrahepatic Cholangiocarcinoma: Development, Growth, Spread, and Prognosis.肝内胆管细胞癌的横断面成像:发展、生长、扩散和预后。
AJR Am J Roentgenol. 2017 Aug;209(2):W64-W75. doi: 10.2214/AJR.16.16923. Epub 2017 Jun 1.
8
Quantification of hepatocellular carcinoma heterogeneity with multiparametric magnetic resonance imaging.多参数磁共振成像定量分析肝细胞癌异质性。
Sci Rep. 2017 May 26;7(1):2452. doi: 10.1038/s41598-017-02706-z.
9
Staging of intrahepatic cholangiocarcinoma.肝内胆管癌的分期
Hepatobiliary Surg Nutr. 2017 Feb;6(1):35-43. doi: 10.21037/hbsn.2016.10.02.
10
The Role of F-18 FDG PET/CT in Intrahepatic Cholangiocarcinoma.F-18 FDG PET/CT在肝内胆管癌中的作用
Nucl Med Mol Imaging. 2017 Mar;51(1):69-78. doi: 10.1007/s13139-016-0440-y. Epub 2016 Aug 6.